Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article, Int J Cardiovasc Res Vol: 2 Issue: 1
B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases
| Habib Haybar1*, Mohammad Davoodi2, Ahmadreza Assareh1, Abtin Shahlaee3, Maryam Azarian4, Zahra Fazelinezhad2 and Amir Eslami Shahr Babaki5 | |
| 1Cardiovascular Research Center, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran | |
| 2Radiology Group, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran | |
| 3Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran | |
| 4Biology Group, North Tehran branch, Islamic Azad University, Tehran, Iran | |
| 5Sports Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran | |
| Corresponding author : Guido Iaccarino Department of Medicine, University of Salerno, Via Salvador Allende, 84081, Baronissi, Salerno, Italy E-mail: giaccarino@unisa.it |
|
| Received: December 12, 2012 Accepted: January 03, 2013 Published: January 21, 2013 | |
| Citation: Cipolletta E, Luca GD, Carillo AL, Annunziata R, Trimarco B, et al. (2013) β2 Adrenergic Receptor Polymorphisms and Treatment-Outcomes in Cardiovascular Diseases. Int J Cardiovasc Res 2:1. doi:10.4172/2324-8602.1000119 |
Abstract
B2 Adrenergic Receptor Polymorphisms and Treatment- Outcomes in Cardiovascular Diseases
Cardiovascular diseases (CVD) represent the major health problem in the western world and heavy social and economic burden. Under this name an eterogenous group of multifactorial conditions is included. There is appreciable inter-individual variability in the susceptibility to cardiovascular disease and in the response to the associated pharmacological treatments. Genetic polymorphism may be, at least in part, responsible for both susceptibility to disease and inter-individual variability in response to pharmacological treatments.
